Citation	Subject	Subject Label	Non grounded Subject	Potential MAXO	Predicate	Object	Object Label	Non grounded Object	Potential HP	Qualifier	Qualifier Label	Non grounded Qualifier	Potential MONDO	Subject Qualifier	Subject Extension	Object Extension	Count
38423591			targeted approach	[]	treats			no specific symptom	[]	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		[]		elexacaftor/tezacaftor/ivacaftor		1
38469782			development of a low cost semiquantitative polymerase chain reaction assay	[]	treats			diagnostic uncertainty	[]			williams beuren syndrome	[('MONDO:0013662', 'syndrome'), ('MONDO:0002254', 'BE')]	low cost	semiquantitative polymerase chain reaction assay		1
38469782			molecular diagnosis	[]	treats			diagnostic uncertainty	[]			williams beuren syndrome	[('MONDO:0013662', 'syndrome'), ('MONDO:0002254', 'BE')]				1
38469782	maxo:0009004	whole exome sequencing		[]	treats			diagnostic uncertainty	[]	mondo:0008678	williams beuren syndrome (wbs)		[]				1
38469782			fluorescence in-situ hybridization (fish)	[]	treats			diagnostic uncertainty	[]	mondo:0008678	williams beuren syndrome (wbs)		[]		fluorescence in-situ hybridization		1
38422338			modified incremental step test (mist)	[]	treats			disease severity	[('HP:0012824', 'Severity')]			non-cystic fibrosis bronchiectasis	[('MONDO:0004822', 'bronchiectasis'), ('MONDO:0009061', 'cystic fibrosis')]				1
38422338			modified incremental step test (mist)	[]	treats	hp:0012378	fatigue		[]			non-cystic fibrosis bronchiectasis	[('MONDO:0004822', 'bronchiectasis'), ('MONDO:0009061', 'cystic fibrosis')]				1
38422338			modified incremental step test (mist)	[]	treats	hp:0002094	dyspnea		[]			non-cystic fibrosis bronchiectasis	[('MONDO:0004822', 'bronchiectasis'), ('MONDO:0009061', 'cystic fibrosis')]				1
38422338			modified incremental step test (mist)	[]	treats			leg fatigue	[('HP:0012378', 'Fatigue'), ('HP:0012378', 'Fatigue')]			non-cystic fibrosis bronchiectasis	[('MONDO:0004822', 'bronchiectasis'), ('MONDO:0009061', 'cystic fibrosis')]				1
38422338			modified incremental step test (mist)	[]	treats			desaturation	[]			non-cystic fibrosis bronchiectasis	[('MONDO:0004822', 'bronchiectasis'), ('MONDO:0009061', 'cystic fibrosis')]				1
38307319			hfcwo therapy	[('MAXO:0001298', 'therapy')]	treats			retained pulmonary secretions	[]			bronchiectasis	[('MONDO:0004822', 'bronchiectasis')]	high frequency	high frequency chest wall oscillation		1
38307319			hfcwo therapy	[('MAXO:0001298', 'therapy')]	treats			exacerbations	[]			bronchiectasis	[('MONDO:0004822', 'bronchiectasis')]	high frequency	high frequency chest wall oscillation		1
38307319			high frequency chest wall oscillation (hfcwo) therapy	[('MAXO:0000514', 'chest wall oscillation'), ('MAXO:0001298', 'therapy')]	prevents			hospitalizations	[]			bronchiectasis	[('MONDO:0004822', 'bronchiectasis')]				1
38154821			improved recognition of lung function decline	[]	prevents			worsening respiratory status	[]	mondo:0009061	cystic fibrosis		[]				1
38154821			treatment	[]	treats			worsening respiratory status	[]	mondo:0009061	cystic fibrosis		[]				1
38154821			follow-up	[]	treats			worsening respiratory status	[]	mondo:0009061	cystic fibrosis		[]				1
38154821			screening and recognition	[]	prevents			decline in forced expiratory volume in one second (fev1)	[]	mondo:0009061	cystic fibrosis		[]				1
38154821			a treatment algorithm	[]	treats			decline in forced expiratory volume in one second (fev1)	[]	mondo:0009061	cystic fibrosis		[]				1
38362632			prolonged-infusion	[('MAXO:0000757', 'infusion')]	treats			in	[]	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		[]		chebi:35627		1
38231535			overexpression	[]	reduces			increased susceptibility	[]	mondo:0005545	staphylococcus aureus		[]		nora (efflux pump)	pyocyanin killing	1
38231535			use of reserpine	[]	increases			increased susceptibility to pyocyanin killing	[]			staphylococcus aureus	[('MONDO:0008757', 'AU'), ('MONDO:0800198', 'AU')]		reserpine		1
38231535			well diffusion assay	[]	measures			larger pyo-created inhibition zone	[]	mondo:0005545	staphylococcus aureus		[]				1
38133654			liver magnetic resonance elastography	[]	treats			liver stiffness	[]	mondo:0009061	cystic fibrosis		[]				1
38133654			liver magnetic resonance spectroscopy	[('MAXO:0009070', 'SPECT')]	treats			hepatosteatosis	[]	mondo:0009061	cystic fibrosis		[]				1
38133654			noninvasive assessment of liver involvement	[]	treats			liver stiffness	[]	mondo:0009061	cystic fibrosis		[]				1
38133654			noninvasive assessment of liver involvement	[]	treats			hepatosteatosis	[]	mondo:0009061	cystic fibrosis		[]				1
38269412			developed updated algorithms	[]	treats			overestimated co2 signal	[]			signal-correction errors in easyone pro lab device	[]				1
38269412			developed updated algorithms	[]	treats			signal-correction errors	[]			easyone pro lab device	[]		easyone pro lab device	uncorrected dependence on humidity	1
38269412			assessed impact on mbw outcomes and frc measurement accuracy	[]	treats			increased difference in frc	[]			signal-correction errors	[]		easyone pro lab device	between eopl and body plethysmography	1
38379863			continuous glucose monitoring	[]	treats			hyperglycemia	[('HP:0003074', 'Hyperglycemia')]			cystic fibrosis-related diabetes	[('MONDO:0005015', 'diabetes'), ('MONDO:0009061', 'cystic fibrosis')]	continuous	glucose monitoring		1
38379863			continuous glucose monitoring	[]	treats			glycemic variability	[]			cystic fibrosis-related diabetes	[('MONDO:0005015', 'diabetes'), ('MONDO:0009061', 'cystic fibrosis')]	continuous	glucose monitoring		1
38379863			2-hour oral glucose tolerance testing (ogtt)	[('MAXO:0000858', 'glucose tolerance test')]	treats			hyperglycemia	[('HP:0003074', 'Hyperglycemia')]			cystic fibrosis-related diabetes	[('MONDO:0005015', 'diabetes'), ('MONDO:0009061', 'cystic fibrosis')]	null	oral glucose tolerance testing	null	1
38379863			hemoglobin a1c (hba1c) measurement	[]	treats			hyperglycemia	[('HP:0003074', 'Hyperglycemia')]			cystic fibrosis-related diabetes	[('MONDO:0005015', 'diabetes'), ('MONDO:0009061', 'cystic fibrosis')]				1
38379863			skin autoflurescence	[]	treats	hp:0003074	hyperglycemia		[]			cystic fibrosis-related diabetes	[('MONDO:0005015', 'diabetes'), ('MONDO:0009061', 'cystic fibrosis')]		chebi:84123		1
38379863			eti use	[]	prevents			pulmonary decline	[]			cystic fibrosis-related diabetes	[('MONDO:0005015', 'diabetes'), ('MONDO:0009061', 'cystic fibrosis')]		elexacaftor/tezacaftor/ivacaftor		1
38379863			use	[]	prevents			weight decline	[]			cystic fibrosis-related diabetes	[('MONDO:0005015', 'diabetes'), ('MONDO:0009061', 'cystic fibrosis')]		chebi:53454	weight decline	1
38153868			use of elexacaftor + tezacaftor + ivacaftor (eti)	[]	prevents			decline in lung function	[]	mondo:0009061	cystic fibrosis		[]		chebi:53454		1
38153868			discontinuation	[]	treats			respiratory symptoms	[]	mondo:0009061	cystic fibrosis		[]		dornase alfa		1
38153868			discontinuation of hypertonic saline	[]	treats			respiratory symptoms	[]			cystic fibrosis	[('MONDO:0009061', 'cystic fibrosis'), ('MONDO:0009061', 'cystic fibrosis')]		hypertonic saline		1
38153868			intermittent use of dornase alfa for symptom relief	[]	treats			respiratory symptoms	[]	mondo:0009061	cystic fibrosis		[]	intermittent	dornase alfa		1
38153868			intermittent use of hypertonic saline for symptom relief	[]	treats			respiratory symptoms	[]	mondo:0009061	cystic fibrosis		[]	intermittent	hypertonic saline		1
38287360			evaluation	[]	treats			chronic bronchopulmonary infections	[('HP:0011010', 'Chronic'), ('HP:0011010', 'Chronic')]			mycobacterium abscessus pulmonary infections	[('MONDO:0005227', 'abscess'), ('MONDO:0005550', 'infection')]		arenicin peptides		1
38287360			insertion into mycobacterial lipids	[]	treats			chronic bronchopulmonary infections	[('HP:0011010', 'Chronic'), ('HP:0011010', 'Chronic')]			mycobacterium abscessus pulmonary infections	[('MONDO:0005227', 'abscess'), ('MONDO:0005550', 'infection')]	with arenicin peptides	arenicin peptides		1
38310629			dose adjustment	[]	treats			forced expiratory volume in the first second (fev1) decrease	[]	mondo:0009061	cystic fibrosis		[]				1
38310629			therapeutic drug monitoring	[]	treats			forced expiratory volume in the first second (fev1) decrease	[]			cystic fibrosis	[('MONDO:0009061', 'cystic fibrosis'), ('MONDO:0009061', 'cystic fibrosis')]		therapeutic drug monitoring		1
38394229			combination treatment to improve mucociliary transport	[]	treats			accumulation of hyperconcentrated mucus	[]	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		[]		combination treatment		1
38394229			disulfide bond reducing agent application	[]	treats			biofilm resistance	[]	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		[]	with tris(2-carboxyethyl)phosphine	chebi:50329		1
38394229			surfactant application	[]	treats			mucus accumulation and obstruction	[]	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		[]	with np40	chebi:63016		1
38394229			biopolymer application	[]	treats			chronic inflammation	[('HP:0011010', 'Chronic'), ('HP:0011010', 'Chronic')]	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		[]	with hyaluronic acid	chebi:16336		1
38394229			dna degradation enzyme application	[]	treats			infection	[]	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		[]	with dnase	dnase		1
38394229			antibiotic administration	[]	treats	hp:0011947	respiratory infections		[]	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		[]	with tobramycin	chebi:28864	acute or chronic	1
38350918			prospective study	[]	prevents			increased risk of future severe exacerbations	[('HP:0012828', 'Severe'), ('HP:0012828', 'Severe')]	mondo:0004822	bronchiectasis		[]				1
38350918			obtained baseline serum hs-crp	[]	treats			reduced lung function	[]	mondo:0004822	bronchiectasis		[]	with hs-crp	hs-crp		1
38350918			follow-up	[]	prevents			increased risk of future severe exacerbations	[('HP:0012828', 'Severe'), ('HP:0012828', 'Severe')]	mondo:0004822	bronchiectasis		[]				1
38377145			spirometric lung function tests	[]	treats			diagnosis	[]	mondo:0004979	asthma		[]	n/a	n/a	n/a	1
38377145			plethysmographic lung function tests	[]	treats			diagnosis	[]	mondo:0011751	copd		[]				1
38377145			spirometric lung function tests	[]	treats			diagnosis	[]			asthma-copd overlap	[('MONDO:0004979', 'asthma'), ('MONDO:0005002', 'COPD')]				1
38377145			lung function tests	[]	treats			diagnosis	[]	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		[]		plethysmographic		1
38377145			linear discriminant analyses	[]	prevents			misclassification	[('HP:0001658', 'MI')]			obstructive lung diseases	[('MONDO:0005275', 'obstructive lung disease'), ('MONDO:0000001', 'lung disease')]		linear discriminant analyses		1
38377145			recursive partitioning decision trees	[]	prevents			misclassification	[('HP:0001658', 'MI')]			obstructive lung diseases	[('MONDO:0005275', 'obstructive lung disease'), ('MONDO:0000001', 'lung disease')]		recursive partitioning decision trees		1
38253430			sweat induction and collection	[]	treats			insufficient sweat volume	[]	mondo:0009061	cystic fibrosis		[]				1
38253430			sweat induction and collection	[]	treats			insufficient sweat volume	[]	mondo:0009061	cystic fibrosis		[]	with	pilocarpine gel		1
38088678			spirometry	[]	treats			obstructive ventilatory disorders	[]	mondo:0009061	cystic fibrosis		[]				1
38088678			impulse oscillometry	[]	treats			compromised peripheral airways	[('HP:0030646', 'Peripheral')]	mondo:0009061	cystic fibrosis		[]				1
38426679			use of cftr modulators	[]	treats			reduced appetite	[]	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		[]	with ivacaftor-tezacaftor-elexacaftor	cftr modulators (with ivacaftor-tezacaftor-elexacaftor)		1
38426679			use of cftr modulators	[]	prevents			low body mass index	[('HP:0500001', 'BO')]	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		[]	with ivacaftor-tezacaftor-elexacaftor	cftr modulators	ivacaftor-tezacaftor-elexacaftor	1
38426679			use of cftr modulators	[]	treats			pulmonary exacerbations	[]	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		[]	with ivacaftor-tezacaftor-elexacaftor	cftr modulators	ivacaftor-tezacaftor-elexacaftor	1
38426679			dose adjustment	[]	prevents			alterations of the liver function	[]	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		[]				1
38426679			clinical and laboratoristic monitoring of hepatic function	[]	prevents			alterations of the liver function	[]			cystic fibrosis	[('MONDO:0009061', 'cystic fibrosis'), ('MONDO:0009061', 'cystic fibrosis')]				1
38092672			sequencing of strains	[]	prevents			resistance	[]	mondo:0009061	cystic fibrosis		[]		murepavadin, colistin, tobramycin		1
38092672			allelic replacement experiments	[]	treats			susceptibility issues	[]	mondo:0009061	cystic fibrosis		[]		murepavadin		1
38286409			monitoring tobramycin trough levels	[]	prevents			increased tobramycin trough levels	[]	mondo:0009061	cystic fibrosis		[]		chebi:28864		1
38286409			intravenous tobramycin treatment	[]	treats			pseudomonas aeruginosa infection	[]	mondo:0009061	cystic fibrosis		[]	with tobramycin	chebi:28864		1
38286409			adjustment of tobramycin dosage	[]	prevents			increased tobramycin trough levels	[]	mondo:0009061	cystic fibrosis		[]		chebi:28864		1
38336730			antimicrobial susceptibility determination	[]	treats	hp:0006532	lung infections		[]			pseudomonas aeruginosa infection	[('MONDO:0005550', 'infection'), ('MONDO:0008713', 'ae')]				1
38336730			next-generation genome sequencing	[('MAXO:0009006', 'genome sequencing')]	prevents			lung infections	[]			pseudomonas aeruginosa infection	[('MONDO:0005550', 'infection'), ('MONDO:0008713', 'ae')]		next-generation genome sequencing		1
38336730			epidemiological investigation	[]	prevents			lung infections	[]			pseudomonas aeruginosa infection	[('MONDO:0005550', 'infection'), ('MONDO:0008713', 'ae')]		epidemiological investigation		1
38336730			antimicrobial susceptibility determination	[]	treats	hp:0006532	lung infections		[]			pseudomonas aeruginosa infection	[('MONDO:0005550', 'infection'), ('MONDO:0008713', 'ae')]	with colistin	chebi:37943		1
38336730			antimicrobial susceptibility determination	[]	treats	hp:0006532	lung infections		[]			pseudomonas aeruginosa infection	[('MONDO:0005550', 'infection'), ('MONDO:0008713', 'ae')]	with amikacin	chebi:2637		1
38336730			antimicrobial susceptibility determination	[]	treats	hp:0006532	lung infections		[]			pseudomonas aeruginosa infection	[('MONDO:0005550', 'infection'), ('MONDO:0008713', 'ae')]	with gentamicin	chebi:17833		1
38336730			antimicrobial susceptibility determination	[]	treats	hp:0006532	lung infections		[]			pseudomonas aeruginosa infection	[('MONDO:0005550', 'infection'), ('MONDO:0008713', 'ae')]	with ceftazidime	chebi:3508		1
38336730			antimicrobial susceptibility determination	[]	treats	hp:0006532	lung infections		[]			pseudomonas aeruginosa infection	[('MONDO:0005550', 'infection'), ('MONDO:0008713', 'ae')]	with piperacillin	chebi:8232		1
38336730			antimicrobial susceptibility determination	[]	treats	hp:0006532	lung infections		[]			pseudomonas aeruginosa infection	[('MONDO:0005550', 'infection'), ('MONDO:0008713', 'ae')]	with piperacillin-tazobactam	piperacillin-tazobactam		1
38336730			antimicrobial susceptibility determination	[]	treats	hp:0006532	lung infections		[]			pseudomonas aeruginosa infection	[('MONDO:0005550', 'infection'), ('MONDO:0008713', 'ae')]	with ciprofloxacin	chebi:100241		1
38336730			antimicrobial susceptibility determination	[]	treats	hp:0006532	lung infections		[]			pseudomonas aeruginosa infection	[('MONDO:0005550', 'infection'), ('MONDO:0008713', 'ae')]	with meropenem	chebi:43968		1
38336730			antimicrobial susceptibility determination	[]	treats	hp:0006532	lung infections		[]			pseudomonas aeruginosa infection	[('MONDO:0005550', 'infection'), ('MONDO:0008713', 'ae')]	with aztreonam	chebi:161680		1
38336730			antimicrobial susceptibility determination	[]	treats	hp:0006532	lung infections		[]			pseudomonas aeruginosa infection	[('MONDO:0005550', 'infection'), ('MONDO:0008713', 'ae')]	with imipenem	chebi:471744		1
38336730			antimicrobial susceptibility determination	[]	treats	hp:0006532	lung infections		[]			pseudomonas aeruginosa infection	[('MONDO:0005550', 'infection'), ('MONDO:0008713', 'ae')]	with cefepime	chebi:478164		1
38336730			antimicrobial susceptibility determination	[]	treats	hp:0006532	lung infections		[]			pseudomonas aerugin	[('MONDO:0008713', 'PSE'), ('MONDO:0015643', 'ae')]	with levofloxacin	chebi:63598		1
38206973			spirometry	[]	treats			impaired mucociliary clearance	[]	mondo:0008932	primary ciliary dyskinesia (pcd) and cystic fibrosis (cf)		[]		spirometry		1
38206973			spirometry	[]	treats			impaired mucociliary clearance	[]	mondo:0009061	cystic fibrosis		[]		spirometry		1
38206973			multiple-breath washout	[]	treats			impaired mucociliary clearance	[]	mondo:0008932	primary ciliary dyskinesia (pcd) and cystic fibrosis (cf)		[]				1
38206973			multiple-breath washout	[]	treats			impaired mucociliary clearance	[]	mondo:0009061	cystic fibrosis		[]				1
38206973			magnetic resonance imaging (mri)	[]	treats			chronic progressive lung disease	[('HP:0002088', 'Lung disease'), ('HP:0003676', 'Progressive')]	mondo:0008932	primary ciliary dyskinesia (pcd) and cystic fibrosis (cf)		[]				1
38206973			magnetic resonance imaging (mri)	[]	treats			chronic progressive lung disease	[('HP:0002088', 'Lung disease'), ('HP:0003676', 'Progressive')]	mondo:0009061	cystic fibrosis		[]				1
38206973			magnetic resonance imaging	[]	treats			chronic rhinosinusitis	[('HP:0011010', 'Chronic'), ('HP:0011010', 'Chronic')]			primary ciliary dyskinesia	[('MONDO:0016575', 'primary ciliary dyskinesia')]		mri		1
38206973			magnetic resonance imaging	[]	treats	hp:0011109	chronic rhinosinusitis (crs)		[]	mondo:0009061	cystic fibrosis		[]				1
38206973			magnetic resonance imaging	[]	treats			consolidations	[]	mondo:0016575	primary ciliary dyskinesia		[]				1
38109903			reanalysis of mbw data	[]	treats			lung disease	[('HP:0002088', 'Lung disease')]			cystic fibrosis	[('MONDO:0009061', 'cystic fibrosis'), ('MONDO:0009061', 'cystic fibrosis')]		mbw data		1
38109903			antibiotic therapy	[('MAXO:0001298', 'therapy')]	treats			pulmonary exacerbation	[]			cystic fibrosis	[('MONDO:0009061', 'cystic fibrosis'), ('MONDO:0009061', 'cystic fibrosis')]		antibiotic		1
38109903			reanalysis of mbw data	[]	treats			pulmonary exacerbation	[]	mondo:0009061	cystic fibrosis		[]	with nitrogen	chebi:25555		1
38266939			development of inhaled dry powder	[]	treats			chronic lower respiratory tract infection	[('HP:0011010', 'Chronic'), ('HP:0011010', 'Chronic')]			chronic lower respiratory tract infection	[('MONDO:0024355', 'respiratory tract infection'), ('MONDO:0005550', 'infection')]		liposomal azithromycin		1
38266939			antimicrobial activity assays	[]	treats			chronic lower respiratory tract infection	[('HP:0011010', 'Chronic'), ('HP:0011010', 'Chronic')]			chronic lower respiratory tract infection	[('MONDO:0024355', 'respiratory tract infection'), ('MONDO:0005550', 'infection')]	with azithromycin	chebi:2955		1
38266939			cytotoxicity and cellular uptake studies	[]	prevents			adverse effects	[]			chronic lower respiratory tract infection	[('MONDO:0024355', 'respiratory tract infection'), ('MONDO:0005550', 'infection')]				1
38059634			intermittent dosing	[]	treats	hp:0006532	lung infections		[]	mondo:0009061	cystic fibrosis		[]		chebi:28001		1
38059634			pharmacokinetics characterization	[]	treats	hp:0006532	lung infections		[]	mondo:0009061	cystic fibrosis		[]	with vancomycin	chebi:28001		1
38059634			therapeutic monitoring	[]	treats	hp:0006532	lung infections		[]	mondo:0009061	cystic fibrosis		[]	with vancomycin	chebi:28001		1
38059634			monte carlo simulations	[]	prevents			toxicity	[]	mondo:0009061	cystic fibrosis		[]	with vancomycin	chebi:28001		1
38059634			target attainment analysis	[]	treats	hp:0006532	lung infections		[]	mondo:0009061	cystic fibrosis		[]	with vancomycin	chebi:28001		1
38411018	maxo:0000624	nutritional assessment		[]	prevents	hp:0004395	malnutrition		[]	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		[]				1
38411018			body composition analysis	[]	prevents	hp:0004395	malnutrition		[]	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		[]				1
38411018			elx/tez/iva therapy	[('MAXO:0001298', 'therapy')]	treats			worsening of pulmonary function	[]	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		[]		elexacaftor-tezacaftor-ivacaftor		1
38400672			kidney transplantation	[('MAXO:0000068', 'transplantation')]	treats			cystic fibrosis	[]				[]				1
38400672			peri-operative morbidity management	[]	prevents			peri-operative complications	[]	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		[]				1
38400672			acute graft rejection intervention	[]	treats			acute graft rejection	[('HP:0011009', 'Acute')]	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		[]				1
38400672			delayed graft function management	[]	treats			delayed graft function	[]	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		[]				1
38169359	maxo:0000530	carrier screening		[]	prevents			birth of child with cystic fibrosis	[]	mondo:0009061	cystic fibrosis		[]				1
38214406			habitual physical activity	[]	prevents			reduced hrqol	[]	mondo:0009061	cystic fibrosis		[]				1
38214406			exercise capacity evaluation	[]	treats			reduced exercise capacity	[]	mondo:0009061	cystic fibrosis		[]				1
38214406			lung function tests	[]	treats			reduced forced expiratory volume in 1 s (ppfev1)	[]	mondo:0009061	cystic fibrosis		[]				1
38214406			body mass index (bmi) calculation	[]	treats			reduced hrqol	[]	mondo:0009061	cystic fibrosis		[]				1
38214406			activity measurement	[]	prevents			sedentary behavior	[]			cystic fibrosis	[('MONDO:0009061', 'cystic fibrosis'), ('MONDO:0009061', 'cystic fibrosis')]	accelerometer use	accelerometer		1
38214406			bicycle ergometry for maximal exercise capacity assessment	[]	treats			reduced exercise capacity	[]	mondo:0009061	cystic fibrosis		[]				1
38214406			cystic fibrosis questionnaire-revised (cfq-r) response analysis	[]	treats			reduced hrqol	[]			cystic fibrosis	[('MONDO:0009061', 'cystic fibrosis'), ('MONDO:0009061', 'cystic fibrosis')]	n/a	n/a	n/a	1
38169175			supplementation	[]	prevents			nutritional status deterioration	[]			cystic fibrosis	[('MONDO:0009061', 'cystic fibrosis'), ('MONDO:0009061', 'cystic fibrosis')]		vitamins		1
38169175			supplementation	[]	treats			nutritional status deterioration	[]	mondo:0009061	cystic fibrosis		[]		pancreatic enzymes		1
38169175			management of nutritional status	[]	prevents			nutritional status deterioration	[]	mondo:0009061	cystic fibrosis		[]				1
38169175			nutrition after organ transplantation	[('MAXO:0000068', 'transplantation'), ('MAXO:0010039', 'organ transplantation')]	treats			nutritional status deterioration	[]	mondo:0009061	cystic fibrosis		[]				1
38168683			combination testing	[]	treats			biofilms	[]	mondo:0009061	cystic fibrosis		[]	with polymyxin b and ethylenediaminetetraacetic acid	polymyxin b, ethylenediaminetetraacetic acid		1
38168683			management of biofilm-associated conditions	[]	treats			biofilms	[]	mondo:0009061	cystic fibrosis		[]				1
38168683			antimicrobial therapy	[('MAXO:0001298', 'therapy')]	treats			biofilms	[]	mondo:0009061	cystic fibrosis		[]	with polymyxin b and ethylenediaminetetraacetic acid	polymyxin b and ethylenediaminetetraacetic acid		1
38168683			antibiofilm therapy	[('MAXO:0001298', 'therapy')]	treats			biofilms	[]	mondo:0009061	cystic fibrosis		[]	with polymyxin b and ethylenediaminetetraacetic acid	polymyxin b and ethylenediaminetetraacetic acid		1
38251578			covid-19 vaccine booster doses	[]	prevents			no detectable igg anti-spike antibodies	[]	mondo:0100096	covid-19		[]		covid-19 vaccine booster doses	no detectable igg anti-spike antibodies	1
38251578			antibody testing	[]	treats			no detectable igg anti-spike antibodies	[]	mondo:0100096	covid-19		[]	using	lateral flow immunoassay tests		1
38251578			immunosuppressive medication	[]	prevents			no detectable igg anti-spike antibodies	[]	mondo:0100096	covid-19		[]	with anti-proliferative agent	anti-proliferative agent		1
38251578			immunosuppressive medication	[]	prevents			no detectable igg anti-spike antibodies	[]	mondo:0100096	covid-19		[]	with	chebi:37153		1
38251578			immunosuppressive medication	[]	prevents			no detectable igg anti-spike antibodies	[]	mondo:0100096	covid-19		[]	with steroids	chebi:35341		1
38251578			immunosuppressive medication	[]	prevents			no detectable igg anti-spike antibodies	[]	mondo:0100096	covid-19		[]	with anti-cd20 therapies	anti-cd20 therapies		1
38426830			cardiopulmonary exercise testing	[]	treats			advanced cystic fibrosis lung disease	[('HP:0002088', 'Lung disease')]				[]				1
38458782			standardising iswt performance	[]	treats			reduced exercise capacity	[]	mondo:0009061	cystic fibrosis		[]				1
38458782			standardising iswt performance	[]	treats			reduced exercise capacity	[]			haemophilia	[('MONDO:0019623', 'HAE')]		iswt		1
38458782			evaluating iswt performance against paediatric normative reference equation	[]	treats			reduced exercise capacity	[]	mondo:0009061	cystic fibrosis		[]		iswt		1
38458782			evaluating iswt performance	[]	treats			reduced exercise capacity	[]			haemophilia	[('MONDO:0019623', 'HAE')]	against paediatric normative reference equation	iswt	paediatric normative reference	1
38458782			association assessment between standardised iswt performance	[]	treats			disease severity	[('HP:0012824', 'Severity')]			cystic fibrosis	[('MONDO:0009061', 'cystic fibrosis'), ('MONDO:0009061', 'cystic fibrosis')]	standardised	iswt		1
38458782			association assessment	[]	treats			disease severity	[('HP:0012824', 'Severity')]			haemophilia	[('MONDO:0019623', 'HAE')]	standardised	iswt		1
38458782			linear regression analysis	[]	prevents			disease severity	[('HP:0012824', 'Severity')]	mondo:0009061	cystic fibrosis		[]				1
38458782			linear regression analysis	[]	prevents			disease severity	[('HP:0012824', 'Severity')]			haemophilia	[('MONDO:0019623', 'HAE')]				1
38233941			intravenous (iv) antibiotic therapy	[('MAXO:0001298', 'therapy')]	treats			pulmonary exacerbation	[]			cystic fibrosis	[('MONDO:0009061', 'cystic fibrosis'), ('MONDO:0009061', 'cystic fibrosis')]	intravenous (iv)	antibiotic		1
38233941			multiple breath washout (mbw) evaluation	[]	assesses			pulmonary exacerbation	[]			cystic fibrosis	[('MONDO:0009061', 'cystic fibrosis'), ('MONDO:0009061', 'cystic fibrosis')]	na	na	na	1
38233941			spirometry	[]	assesses			pulmonary exacerbation	[]	mondo:0009061	cystic fibrosis		[]				1
38114870			whole-exome sequencing	[('MAXO:0009004', 'exome sequencing')]	prevents	hp:0000027	azoospermia		[]			congenital obstructive azoospermia	[('MONDO:0100459', 'azoospermia'), ('MONDO:0021140', 'congenital')]				1
38114870			semen parameters evaluation	[]	treats	hp:0000027	azoospermia		[]			congenital obstructive azoospermia	[('MONDO:0100459', 'azoospermia'), ('MONDO:0021140', 'congenital')]				1
38114870			sex hormones evaluation	[]	treats	hp:0000027	azoospermia		[]			congenital obstructive azoospermia	[('MONDO:0100459', 'azoospermia'), ('MONDO:0021140', 'congenital')]		sex hormones evaluation		1
38114870			seminal plasma biochemistry evaluation	[]	treats	hp:0000027	azoospermia		[]			congenital obstructive azoospermia	[('MONDO:0100459', 'azoospermia'), ('MONDO:0021140', 'congenital')]				1
38114870			surgical sperm extraction-intracytoplasmic sperm injection (icsi) treatment	[]	treats	hp:0000027	azoospermia		[]			congenital obstructive azoospermia	[('MONDO:0100459', 'azoospermia'), ('MONDO:0021140', 'congenital')]				1
38114870	maxo:0000079	genetic counseling		[]	prevents	hp:0000027	azoospermia		[]			congenital obstructive azoospermia	[('MONDO:0100459', 'azoospermia'), ('MONDO:0021140', 'congenital')]				1
38309533			stepwise algorithm incorporation	[]	prevents			overuse of ogtt	[]			cystic fibrosis-related diabetes	[('MONDO:0005015', 'diabetes'), ('MONDO:0009061', 'cystic fibrosis')]				1
38309533			composite index	[]	prevents			overuse of ogtt	[]			cystic fibrosis-related diabetes	[('MONDO:0005015', 'diabetes'), ('MONDO:0009061', 'cystic fibrosis')]	with hba1c, homa2	dipic formulation		1
38128948			bilateral lung transplantation	[('MAXO:0000068', 'transplantation')]	treats			cystic fibrosis	[]			paediatric cystic fibrosis	[('MONDO:0009061', 'cystic fibrosis'), ('MONDO:0009061', 'cystic fibrosis')]				1
38128948	maxo:0001351	occupational therapy		[]	treats			"""big problems"" with self-care tasks"	[]	mondo:0009061	cystic fibrosis		[]				1
38128948	maxo:0001351	occupational therapy		[]	treats			family engagement issues	[]	mondo:0009061	cystic fibrosis		[]				1
38128948	maxo:0001351	occupational therapy		[]	treats			coping with worries	[]	mondo:0009061	cystic fibrosis		[]				1
38128948	maxo:0001351	occupational therapy		[]	treats			issues with community engagement	[]	mondo:0009061	cystic fibrosis		[]				1
38128948	maxo:0001351	occupational therapy		[]	treats			problems with independence	[]	mondo:0009061	cystic fibrosis		[]				1
38296344			systemic antibiotic treatment	[]	treats			p. aeruginosa infection	[]			bronchiectasis	[('MONDO:0004822', 'bronchiectasis')]		antibiotic		1
38296344			inhaled antibiotic treatment	[]	treats			p. aeruginosa infection	[]	mondo:0004822	bronchiectasis		[]	inhaled	chebi:33281		1
38296344			combined systemic and inhaled antibiotic treatment	[]	treats			p. aeruginosa infection	[]	mondo:0004822	bronchiectasis		[]	with antibiotics	chebi:33281		1
38184455			bronchial artery embolisation	[('MAXO:0000573', 'ART')]	treats	hp:0002105	haemoptysis		[]	mondo:0009061	cystic fibrosis		[]				1
38184455			imaging symptomatic patients	[]	prevents			neurovascular complications	[]	mondo:0009061	cystic fibrosis		[]				1
38254935			genetic monitoring	[]	prevents			azoospermia-related male infertility	[('HP:0000027', 'Azoospermia'), ('HP:0000789', 'Infertility')]	mondo:0009061	cystic fibrosis		[]		genetic monitoring		1
38254935			genotyping	[]	treats			azoospermia-related male infertility	[('HP:0000027', 'Azoospermia'), ('HP:0000789', 'Infertility')]	mondo:0009061	cystic fibrosis		[]		genotyping		1
38346040			ceragenin csa-13 (with dnase i) treatment	[]	treats			elevated viscosity and elasticity	[]	mondo:0009061	cystic fibrosis		[]	with dnase i	ceragenin csa-13		1
38346040			ceragenin csa-13 (with poly-aspartic acid (pasp))	[]	treats			elevated viscosity and elasticity	[]	mondo:0009061	cystic fibrosis		[]		ceragenin csa-13		1
38268067			8-week remotely supervised resistance training program	[]	treats			reduced muscle strength	[]	mondo:0009061	cystic fibrosis		[]				1
38268067			8-week remotely supervised resistance training program	[]	treats			altered body composition	[('HP:0500001', 'BO')]			cystic fibrosis	[('MONDO:0009061', 'cystic fibrosis'), ('MONDO:0009061', 'cystic fibrosis')]		resistance training		1
38275615			genetic screening	[]	prevents	hp:0001263	developmental delay		[]	mondo:0012084	aromatic l-amino acid decarboxylase deficiency (aadcd)		[]				1
38275615			molecular investigation	[]	prevents			undiagnosed neurological disorders	[]			aromatic l-amino acid decarboxylase deficiency (aadcd)	[('MONDO:0012084', 'aromatic L-amino acid decarboxylase deficiency'), ('MONDO:0012084', 'aromatic L-amino acid decarboxylase deficiency')]				1
38441982			use of hnp-1 and hbd-3	[]	treats			multidrug-resistant eskape gram-negatives	[]			multidrug-resistant eskape gram-negatives	[('MONDO:0007080', 'MUL'), ('MONDO:0009664', 'RE')]		hnp-1 and hbd-3		1
38441982			combination with lysozyme	[]	treats			multidrug-resistant eskape gram-negatives	[]			multidrug-resistant eskape gram-negatives	[('MONDO:0007080', 'MUL'), ('MONDO:0009664', 'RE')]		lysozyme		1
38441982			combination with colistin	[]	treats			multidrug-resistant eskape gram-negatives	[]			multidrug-resistant eskape gram-negatives	[('MONDO:0007080', 'MUL'), ('MONDO:0009664', 'RE')]	with colistin	colistin		1
38441982			combination with meropenem	[]	treats			multidrug-resistant eskape gram-negatives	[]			multidrug-resistant eskape gram-negatives	[('MONDO:0007080', 'MUL'), ('MONDO:0009664', 'RE')]	with meropenem	chebi:43968		1
38132670			genomic analyses	[]	treats			p. aeruginosa lung infection	[]			patient	[]				1
38431897	maxo:0000118	immunization		[]	prevents			covid-19 infection	[]	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		[]				1
38057039			initialization of elexacaftor-tezacaftor-ivacaftor therapy	[('MAXO:0001298', 'therapy')]	treats	hp:0004395	malnutrition		[]	mondo:0009061	cystic fibrosis		[]		elexacaftor-tezacaftor-ivacaftor		1
38057039			initialization of therapy	[('MAXO:0001298', 'therapy')]	treats			cystic fibrosis related diabetes (cfrd)	[]	mondo:0009061	cystic fibrosis		[]		elexacaftor-tezacaftor-ivacaftor		1
38057039			initialization of elexacaftor-tezacaftor-ivacaftor therapy	[('MAXO:0001298', 'therapy')]	treats	hp:0040270	impaired glucose tolerance (igt)		[]	mondo:0009061	cystic fibrosis		[]		elexacaftor-tezacaftor-ivacaftor		1
38057039			reduction or cessation of insulin therapy	[('MAXO:0000259', 'insulin therapy'), ('MAXO:0001298', 'therapy')]	treats			cystic fibrosis related diabetes (cfrd)	[]	mondo:0009061	cystic fibrosis		[]		chebi:145810		1
38054992			annual follow-up	[]	prevents			progression to cystic fibrosis	[]			cfspid	[('MONDO:0005404', 'CFS'), ('MONDO:0009061', 'CF')]				1
38054992			evaluation of sweat chloride values	[]	treats			pathological sweat chloride values (>= 60 mmol/l)	[]			cystic fibrosis	[('MONDO:0009061', 'cystic fibrosis'), ('MONDO:0009061', 'cystic fibrosis')]				1
38054992			assessment of lung function	[]	prevents			lung dysfunction	[]	mondo:0009061	cystic fibrosis		[]				1
38054992			diagnosis of cf or cftr-related disorders	[]	treats			multi-organ involvement	[]	mondo:0009061	cystic fibrosis		[]				1
38054992			annual follow-up	[]	prevents			progression to cystic fibrosis	[]			cfspid	[('MONDO:0005404', 'CFS'), ('MONDO:0009061', 'CF')]	with assessment of abnormal lci2.5			1
38135160			targeted drug delivery to the pulmonary system	[]	treats	hp:0002094	difficulty breathing		[]	mondo:0009061	cystic fibrosis		[]				1
38135160			targeted drug delivery to the pulmonary system	[]	treats			large accumulation of mucus in the respiratory tract	[]	mondo:0009061	cystic fibrosis		[]				1
38135160	maxo:0001298	therapy		[]	treats			serious bacterial infections	[]	mondo:0009061	cystic fibrosis		[]		nanoparticle-based		1
38135160			traditional drug-based treatments	[]	treats			difficulty breathing	[('HP:0002094', 'Difficulty breathing')]			cystic fibrosis	[('MONDO:0009061', 'cystic fibrosis'), ('MONDO:0009061', 'cystic fibrosis')]		traditional drug-based treatments		1
38135160			traditional drug-based treatments	[]	treats			large accumulation of mucus in the respiratory tract	[]	mondo:0009061	cystic fibrosis		[]		traditional drug-based treatments		1
38236037			use of amikacin	[]	treats			growth of mycobacterium abscessus	[('HP:0025615', 'Abscess')]			mycobacterium abscessus pulmonary disease	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]		chebi:2637		1
38236037			short-interval dosing	[]	treats			growth of mycobacterium abscessus	[('HP:0025615', 'Abscess')]			mycobacterium abscessus pulmonary disease	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]	with amikacin	chebi:2637		1
38236037			short-interval dosing	[]	prevents			resistance emergence	[]			mycobacterium abscessus pulmonary disease	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]	with amikacin	chebi:2637		1
38236037			extended-interval dosing	[]	treats			growth of mycobacterium abscessus	[('HP:0025615', 'Abscess')]			mycobacterium abscessus pulmonary disease	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]	with amikacin	chebi:2637		1
38236037			extended-interval dosing	[]	fails to prevent			resistance emergence	[]			mycobacterium abscessus pulmonary disease	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]	with amikacin	chebi:2637		1
38179878			retrospective study	[]	treats			changes in body mass index	[('HP:0500001', 'BO')]	mondo:0009061	cystic fibrosis		[]				1
38179878			retrospective study	[]	treats			changes in serum lipids	[]			cystic fibrosis	[('MONDO:0009061', 'cystic fibrosis'), ('MONDO:0009061', 'cystic fibrosis')]				1
38179878			retrospective study	[]	treats			changes in fat-soluble vitamin levels	[]			cystic fibrosis	[('MONDO:0009061', 'cystic fibrosis'), ('MONDO:0009061', 'cystic fibrosis')]				1
38179878			elexacaftor/tezacaftor/ivacaftor (eti) therapy	[('MAXO:0001298', 'therapy')]	treats			changes in body mass index	[('HP:0500001', 'BO')]	mondo:0009061	cystic fibrosis		[]		chebi:53454		1
38179878	maxo:0001298	therapy		[]	treats			changes in serum lipids	[]	mondo:0009061	cystic fibrosis		[]		chebi:53454		1
38272397	maxo:0001001	gene therapy		[]	treats			mutations in the cf transmembrane conductance regulator (cftr) gene	[]	mondo:0009061	cystic fibrosis		[]				1
38272397			gene delivery vectors	[]	treats			mutations	[]	mondo:0009061	cystic fibrosis		[]		highly branched poly(beta-amino ester) (hpae)	mutations in the cf transmembrane conductance regulator (cftr) gene	1
38272397			backbone cationization strategy	[]	treats			lung cystic fibrosis (cf)	[('HP:0032445', 'Lung cyst')]	mondo:0009061	cystic fibrosis		[]		backbone cationization strategy	mutations in the cf transmembrane conductance regulator (cftr) gene	1
38272397			reinstatement of cftr protein expression	[]	treats			dysfunctional cftr protein	[]	mondo:0009061	cystic fibrosis		[]	with 1-(3-aminopropyl)-4-methylpiperazine (e7)	1-(3-aminopropyl)-4-methylpiperazine (e7)		1
38386889			pancreatic enzyme replacement therapy (pert)	[('MAXO:0001298', 'therapy')]	treats			low fecal elastase-1 levels	[]	mondo:0001684	exocrine pancreatic insufficiency (epi)		[]		pancreatic enzyme replacement therapy		1
38088381			measurement of nasal nitric oxide	[]	prevents			misdiagnosis	[('HP:0001658', 'MI')]	mondo:0016575	primary ciliary dyskinesia		[]				1
38088381			use of chemiluminescence device	[]	treats			diagnostic challenges	[]			primary ciliary dyskinesia	[('MONDO:0016575', 'primary ciliary dyskinesia')]		chemiluminescence		1
38088381			use of devices based on electrochemical sensors	[]	treats			diagnostic challenges	[]	mondo:0008932	primary ciliary dyskinesia (pcd) and cystic fibrosis (cf)		[]		electrochemical sensors		1
38088381			following standardized guidelines	[]	prevents			diagnostic errors	[]			primary ciliary dyskinesia	[('MONDO:0016575', 'primary ciliary dyskinesia')]	not applicable	not applicable	not applicable	1
38291686			harmonizing the description	[]	prevents			variations	[]			cfhbi	[('MONDO:0009061', 'CF')]				1
38291686			providing a reliable account	[]	treats			hepatobiliary involvement	[]			cfhbi	[('MONDO:0009061', 'CF')]				1
38291686			supporting the development of clinical outcomes	[]	treats			hepatobiliary involvement	[]			cfhbi	[('MONDO:0009061', 'CF')]				1
38291686			developing a systematic classification	[]	prevents			variations	[]				[]		cfhbi		1
38291686			achieving validation for clinical practice and research	[]	prevents			inaccuracies	[]			cfhbi	[('MONDO:0009061', 'CF')]	na	cfhbi	na	1
38179886			modulator therapy	[('MAXO:0001298', 'therapy')]	treats			cystic fibrosis	[]				[]				1
38179886			mbnw	[]	assesses			small airway disease (sad)	[]	mondo:0009061	cystic fibrosis		[]				1
38179886			spirometry	[]	assesses	hp:0006536	airway obstruction		[]	mondo:0009061	cystic fibrosis		[]				1
38356031			pulmonary drug delivery	[]	treats			respiratory disorders	[]			respiratory disorders	[('MONDO:0000001', 'respiratory disorder'), ('MONDO:0000001', 'disorder')]		pulmonary drug delivery		1
38356031			local targeting to the lungs	[]	treats			respiratory disorders	[]			respiratory disorders	[('MONDO:0000001', 'respiratory disorder'), ('MONDO:0000001', 'disorder')]				1
38356031			noninvasive pulmonary delivery	[]	prevents			systemic side effects	[]			respiratory disorders	[('MONDO:0000001', 'respiratory disorder'), ('MONDO:0000001', 'disorder')]	noninvasive	pulmonary delivery		1
38356031			systemic absorption	[]	treats			respiratory disorders	[]	mondo:0005087	respiratory disorders		[]				1
38269943			application	[]	treats			lung perfusion changes	[]	mondo:0009061	cystic fibrosis		[]		explainable artificial intelligence algorithms		1
38269943			application of explainable artificial intelligence algorithms	[('MAXO:0000573', 'ART')]	treats			mucus plugging	[('HP:0025695', 'Mucus plug')]	mondo:0009061	cystic fibrosis		[]				1
38269943			use of deep learning-based classification pipeline	[]	treats			lung perfusion changes	[]			cystic fibrosis	[('MONDO:0009061', 'cystic fibrosis'), ('MONDO:0009061', 'cystic fibrosis')]		deep learning-based classification pipeline		1
38269943			use	[]	treats			mucus plugging	[('HP:0025695', 'Mucus plug')]	mondo:0009061	cystic fibrosis		[]		deep learning-based classification pipeline		1
38327061			video-assisted thoracoscopic surgery (vats)	[('MAXO:0000004', 'surgery')]	treats			postoperative pain	[('HP:0012531', 'Pain'), ('HP:0012531', 'Pain')]			non-cystic fibrosis bronchiectasis in children	[('MONDO:0004822', 'bronchiectasis'), ('MONDO:0017014', 'cystic fibrosis')]				1
38327061			video-assisted thoracoscopic surgery (vats)	[('MAXO:0000004', 'surgery')]	treats			intraoperative blood loss	[]			non-cystic fibrosis bronchiectasis in children	[('MONDO:0004822', 'bronchiectasis'), ('MONDO:0017014', 'cystic fibrosis')]				1
38327061			video-assisted thoracoscopic surgery (vats)	[('MAXO:0000004', 'surgery')]	treats			transfusion status	[]			non-cystic fibrosis bronchiectasis in children	[('MONDO:0004822', 'bronchiectasis'), ('MONDO:0017014', 'cystic fibrosis')]				1
38327061			video-assisted thoracoscopic surgery (vats)	[('MAXO:0000004', 'surgery')]	treats			postoperative mechanical ventilation time	[]			non-cystic fibrosis bronchiectasis in children	[('MONDO:0004822', 'bronchiectasis'), ('MONDO:0017014', 'cystic fibrosis')]				1
38327061			video-assisted thoracoscopic surgery (vats)	[('MAXO:0000004', 'surgery')]	treats			chest tube drainage time	[]			non-cystic fibrosis bronchiectasis in children	[('MONDO:0004822', 'bronchiectasis'), ('MONDO:0017014', 'cystic fibrosis')]				1
38327061			video-assisted thoracoscopic surgery (vats)	[('MAXO:0000004', 'surgery')]	treats			length of hospital stay	[]			non-cystic fibrosis bronchiectasis in children	[('MONDO:0004822', 'bronchiectasis'), ('MONDO:0017014', 'cystic fibrosis')]				1
38327061			video-assisted thoracoscopic surgery (vats)	[('MAXO:0000004', 'surgery')]	treats			incidence of complications	[]			non-cystic fibrosis bronchiectasis in children	[('MONDO:0004822', 'bronchiectasis'), ('MONDO:0017014', 'cystic fibrosis')]				1
38150545	maxo:0000016	cell therapy		[]	treats			airway epithelium injury	[]	mondo:0009061	cystic fibrosis		[]				1
38150545			droplet digital pcr	[]	measures			chimerism	[]	mondo:0009061	cystic fibrosis		[]				1
38150545			conditionally reprogrammed cell culture methods	[]	improve			cell engraftment efficiency	[]			cystic fibrosis	[('MONDO:0009061', 'cystic fibrosis'), ('MONDO:0009061', 'cystic fibrosis')]		conditionally reprogrammed cell culture methods		1
38150545			irradiating	[]	treats			competition for space in the airway epithelium	[]	mondo:0009061	cystic fibrosis		[]				1
38150545			viral preconditioning	[]	treats			airway epithelium injury	[]	mondo:0009061	cystic fibrosis		[]				1
38430625			continuous glucose monitoring	[]	treats			declining lung function	[]			cystic fibrosis related diabetes (cfrd)	[('MONDO:0005015', 'diabetes'), ('MONDO:0009061', 'cystic fibrosis')]	with glucose	chebi:17234		1
38430625			2-h standard oral glucose tolerance testing	[('MAXO:0000858', 'glucose tolerance test')]	treats			nutritional status decline	[]			cystic fibrosis related diabetes (cfrd)	[('MONDO:0005015', 'diabetes'), ('MONDO:0009061', 'cystic fibrosis')]	with glucose	chebi:17234		1
38309959			methacholine challenge test (mct)	[]	treats	hp:0032933	airway hyperresponsiveness		[]	mondo:0004979	bronchial asthma		[]		chebi:6804		1
38309959			inhalation of bronchodilator	[]	treats			breathlessness	[]				[]	with salbutamol or ipratropium bromide	chebi:2549		1
38309959			wheezing	[]	in	hp:0002099	bronchial asthma		[]				[]				1
38309959			quality control of mct equipment	[]	prevents			inadequate inhalation	[]	mondo:0004979	bronchial asthma		[]		chebi:50142		1
38309959			interpreting mct results	[]	treats			diagnosis uncertainty	[]	mondo:0004979	bronchial asthma		[]		mct		1
38309959			managing adverse reactions and safety measures	[]	prevents			life-threatening situations	[]			bronchial asthma	[('MONDO:0004979', 'asthma'), ('MONDO:0007113', 'AS')]		mct		1
38423592			targeted approach	[]	treats			cystic fibrosis	[]				[]		elexacaftor/tezacaftor/ivacaftor		1
38270329			data collection	[]	prevents			increase in body mass index (bmi)	[('HP:0500001', 'BO')]	mondo:0009061	cystic fibrosis		[]				1
38270329			pubertal and endocrine data analysis	[]	prevents			impaired final height	[]			cystic fibrosis	[('MONDO:0009061', 'cystic fibrosis'), ('MONDO:0009061', 'cystic fibrosis')]		pubertal and endocrine data analysis		1
38270329			data collection	[]	prevents			early adrenarche	[]	mondo:0009061	cystic fibrosis		[]				1
38270329			pubertal and endocrine data analysis	[]	prevents			accelerated bone age	[('HP:0500001', 'BO')]			cystic fibrosis	[('MONDO:0009061', 'cystic fibrosis'), ('MONDO:0009061', 'cystic fibrosis')]		pubertal and endocrine data analysis		1
38070531			use of an international consensus-based core outcome set (cos)	[]	prevents			exacerbation frequency	[('HP:0040279', 'Frequency')]			non-cystic fibrosis bronchiectasis	[('MONDO:0004822', 'bronchiectasis'), ('MONDO:0009061', 'cystic fibrosis')]		chebi:17245		1
38070531			use	[]	prevents			non-scheduled health-care visits	[]			non-cystic fibrosis bronchiectasis	[('MONDO:0004822', 'bronchiectasis'), ('MONDO:0009061', 'cystic fibrosis')]		chebi:17245		1
38070531			use of an international consensus-based core outcome set (cos)	[]	prevents			hospitalisations	[]			non-cystic fibrosis bronchiectasis	[('MONDO:0004822', 'bronchiectasis'), ('MONDO:0009061', 'cystic fibrosis')]		chebi:17245		1
